ScholarLens Back to search
2015•Annals of the Rheumatic DiseasesRequires access

A8.4 IL4–10 synerkine: a novel anti-inflammatory drug to inhibit immunopathology in inflammatory rheumatic diseases

SAY Hartgring, C. Steen-Louws, M De Smet, C. Erik Hack, JAG van Roon

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Interleukin 10, Interleukin 4, Proinflammatory cytokine, Medicine, Immunology, Inflammation, Receptor, Interleukin

Related papers

Related paper 1Related paper 2
Back to paper searchBrowse research topicsOriginal source
A8.4 IL4–10 synerkine: a novel anti-inflammatory drug to inhibit immunopathology in inflammatory rheumatic diseases — Research Paper | ScholarLens